UC Davis to Test Experimental Drug for Treating Laminitis
Edited Press Release
November 15, 2012
Veterinarians plan to conduct a trial of an experimental drug that has shown promise in treating laminitis.
Veterinarians plan to conduct a trial of an experimental drug that has shown promise in treating laminitis.
Steve Haskin provides an update on Paynter’s recovery at Fair Hill Equine Therapy Center.
EVJ has made a collection of laminitis research papers available online to both vets and horse owners.
The two-day program included presentations about podiatry, diagnostics, and treatments for laminitis.
Dr. Nora Grenager answers a user’s question about the human correlate of laminitis at the 2012 International Equine Conference on Laminitis and Diseases of the Foot. The answer might surprise you.
Veterinarian and farrier Dr. Raul Bras answers a user’s question concerning broodmares and laminitis at the 2012 International Equine Conference on Laminitis and Diseases of the Foot.
Dr. James Orsini shares the importance of bringing vets and farriers together to discuss laminitis at the 2012 International Equine Conference on Laminitis and Diseases of the Foot.
This year’s event features a horse owner program covering advancements in laminitis research and more.
Topical cisplatin chemotherapy yielded promising results for treating canker in a small trial.
Zayat, commenting Oct. 12, said the intent is to eventually return Paynter to training.
Steve Haskin shares his thoughts on racehorse Paynter’s multiple medical battles and his recovery.
Endocrinology researchers met to discuss equine metabolic syndrome (EMS) and equine Cushing’s disease (PPID).
Paynter has “beaten laminitis” and will be able to race again if he beats colitis, his owner said Sept. 21.
Don Walsh, DVM, answers questions about The 2012 Equine Endocrinology Summit and how it relates to laminitis.
The coordinators of the ongoing laminitis research project have expanded the inclusion criteria.
Stay on top of the most recent Horse Health news with
